best wordpress themes

Need help? Write to us [email protected]

Сall our consultants or Chat Online

+1(912)5047648

Toxta vs Hutox: Which Korean Botulinum Toxin Fits Your Buying Priorities?

Toxta vs Hutox: Korean botulinum toxin product comparison
Buyer’s Guide  ·  Korean Botulinum Toxin Type A

Toxta vs Hutox: Which Korean Botulinum Toxin Fits Your Buying Priorities?

Two value-tier Korean type A brands — vacuum-dried against freeze-dried. Same molecule, different vials, and a few honest differences that decide which one your practice should stock.

3–7 days
Onset for both brands
3–6 months
Duration, mainstream reports
~99.8%
Purity claim on both labels
MFDS only
Neither is FDA / CE approved

01Quick Answer

Read this paragraph; it is the whole comparison in one breath.

Toxta and Hutox are both value-tier Korean botulinum toxin type A products with the same ~99.8% purity claim. The most obvious difference is physical: Toxta is vacuum-dried and arrives as a nearly empty-looking vial with a thin, almost invisible film, while Hutox is a freeze-dried powder with a visible white cake. Realistic expectations for both: onset 3–7 days, full effect by week two, duration 3–6 months. Neither is FDA or CE approved — both are MFDS-approved.

Bottom linePick on the two things that actually differ — physical form and protein story — not on onset, duration or purity, where the two brands report the same numbers.

02The #1 Difference — How the Product Arrives

This is the first thing you notice when a box is opened, and it is not a cosmetic detail — it changes how you receive, check and reconstitute the vial.

Toxta · JETEMA

Vacuum-dried — and it looks empty

Vacuum / negative-pressure drying

An ultra-thin, almost invisible film sits on the inside of the vial. A sealed, untouched vial can genuinely look empty — this is the signature of the process, not a missing dose and not a packaging error.

Hold it to the light at an angle to see the faint film.

Hutox · Huons

Freeze-dried powder

Conventional lyophilization

A visible white powder cake sits at the bottom of the vial — the form most practitioners are used to seeing. Reconstitution behaviour is unmistakable: the powder visibly dissolves.

What you see is what you get — no surprises at intake.

Same after reconstitutionBoth dissolve with preservative-free saline into a clear, colourless solution. The routine is identical: add saline, swirl gently, never shake. The difference is purely in what the vial looks like before you add liquid.

03Who Makes Each One

Both come from KOSDAQ-listed Korean biotech companies that run their own production lines — neither is a contract-filled import.

Toxta

JETEMA Co., Ltd.

Korean biopharmaceutical company with a dedicated toxin facility. Toxta’s strain is described by JETEMA as a European-origin proprietary strain. The same production platform makes Kaimax, a sister brand sharing the strain and the vacuum-drying process — Toxta is one of two twins, not a one-off.

Hutox

Huons Biopharma (Huons Global)

Hutox is the English-market export name for the product Korea’s domestic market sells as Liztox — same formulation, different label for international sales. That one fact clears up most of the confusion in seller listings.

One misconception, clearedNo reliable source describes Hutox as a ready-to-use liquid. Like every other type A in this lineup, it is a dried powder that must be reconstituted.

For a field view of where Toxta and Hutox sit among the other Korean botox brands, our eight-brand comparison covers the full lineup side by side.

04What Is Actually In Each Vial

Same active molecule, same excipients, identical purity figure — and one real formulation difference.

Inside both vials: Clostridium botulinum toxin type A, stabilized with human serum albumin (0.5 mg) and sodium chloride. Both labels quote ~99.8% purity.

Don’t be sold on purity~99.8% is the same manufacturer-reported figure on both labels. It is not a differentiator in this match-up — both quote the same number.

The difference that actually matters is protein.

Toxta

Reduced-protein complex

A neurotoxin complex with protein content cut roughly 55% versus conventional formulations (per JETEMA), linked by the manufacturer to lower antibody risk over repeated sessions.

Hutox

150 kDa core toxin, no complexing proteins

Purified down to the 150 kDa core neurotoxin without complexing proteins — the basis of its “low immunogenicity” positioning.

Both are selling the same story — less protein, less immune stimulation — through different manufacturing routes. And the spec you actually need fits in one line: both come in 100U vials, Toxta also in 200U. Units, not packaging, are the working currency.

05Onset and Results

The realistic window for both products is the same. Anyone promising faster is selling marketing, not pharmacology.

Day 0
Treatment
Day 3–7
First softening appears
Day 10–14
Full effect / peak smoothness
Month 3–6
Movement gradually returns
Toxta

Seller claims diverge most here

Distributors quote anything from 2–3 days to 5–14 days. Treat the optimistic figures as distributor claims — the consistent real-world report is roughly 3–7 days, in line with the rest of the Korean type A field.

Hutox

Reports cluster at 3–7 days

Consistent with its domestic twin Liztox, which has years of accumulated Korean-market use. Nothing in its published data supports a materially faster onset than Toxta.

Watch out“Two days, guaranteed” is a distributor claim, not clinical reality. Same for Hutox “hits faster” — that is comparing marketing sheets, not vials.

06Duration and Treatment Course

Duration is where the gap between honest data and seller copy is widest — for both brands, but especially for Toxta.

Toxta

3–6 months (mainstream)

Several distributors advertise 6–9 months. The commonly cited clinical figure is closer to four months. If a supplier quotes 6–9 months, ask for the source.

Hutox

3–6 months (3–4 typical in Korea)

Sits in the same band as Toxta. No credible source puts either brand meaningfully above the other on duration — individual metabolism and muscle mass shift these numbers more than the brand name does.

The 6–9 month figureThat number is a distributor claim, not clinical reality. This article’s job is to say so plainly.
Standard courseFirst treatment peaks at day 14. Re-treatment interval: minimum 3 months. Most clients settle at 2–3 sessions a year. Repeat treatment is maintenance, not stacked dosing — never drop below 3 months.

07Diffusion and Precision

How far the product spreads from the injection point separates product choice by body area.

Hutox

Narrow — precision-oriented

Tighter diffusion suits precision-critical zones: glabella, periorbital crow’s feet, brow-shaping — where one millimetre of unintended migration shows up as a heavy brow or an asymmetric lift.

Toxta

Balanced — controlled spread

Enough spread for even coverage across larger zones — forehead, masseter, full-face work — without runaway spread.

Why units are not interchangeableSame injection plan, different spread behaviour means different results. The dose that looks right on a Hutox map is not automatically right on a Toxta one — recalibrate when switching.

08Side Effects and Post-Treatment Protocol

The side effect profile of both is that of botulinum toxin type A generally — and technique matters more than the label on the vial.

What you may see: temporary injection-site redness or swelling that usually resolves within hours, an occasional mild headache for a day or two, and — rare but worth knowing — temporary eyelid or brow heaviness if the product spreads beyond the intended muscle. These risks are operator-dependent far more than brand-dependent.

On antibodies: both market the same theoretical advantage by different routes — Hutox removes complexing proteins entirely, Toxta cuts protein load. The theory is sound, but at cosmetic dosing, real-world antibody failure is rare for either brand.

Post-treatment protocol — applies to both brands:

  • 1Stay upright for 4 hours after treatment — no lying down, no face-down positions.
  • 2Do not rub, massage or press the area for 24 hours. This is the single most important rule — pressure moves the product.
  • 3Avoid heat exposure (sauna, steam room, hot yoga, heavy cardio) for 24–48 hours — heat accelerates circulation and can affect distribution.
  • 4Avoid alcohol for 24 hours — it dilates blood vessels and increases bruising risk.
  • 5Skip facials, chemical peels and facial massage for 48 hours.
  • 6Light exercise after 24 hours; intense training after 48 hours.
  • 7For mild headache, paracetamol is acceptable; avoid aspirin and ibuprofen, which thin blood and worsen bruising.
  • 8Book a review at day 14 — when full effect is visible and any asymmetry can be corrected with a small top-up.

09Full Comparison Table

Every dimension, side by side. The first row is the difference that matters most.

Dimension Toxta (JETEMA) Hutox (Huons Biopharma)
Product form Vacuum-dried — near-empty-looking vial with a thin, almost invisible film Freeze-dried — visible white powder cake in the vial
Manufacturer JETEMA Co., Ltd. (KOSDAQ) Huons Biopharma / Huons Global
Domestic Korean name Toxta Liztox
Active ingredient BoNT-A, European-origin proprietary strain BoNT-A, BioPure process
Purity (manufacturer claim) ~99.8% ~99.8%
Protein Reduced-protein complex (~55% lower, per JETEMA) 150 kDa core toxin without complexing proteins
Onset 3–7 days some distributors claim 2–3 3–7 days
Duration 3–6 months some claim 6–9 3–6 months
Diffusion Balanced, controlled — suits broader zones Narrow — suits precision areas
Regulatory MFDS-approved; not FDA/CE approved MFDS-approved; not FDA/CE approved
Shelf life 36 months from manufacture Standard Korean-market shelf life
Best for Cost-driven, high-volume buyers; clinics holding slow inventory Precision facial work; buyers who want the protein-free formulation

10Price, Supply and Authenticity

The part buyers actually feel — and the part where the market’s biggest traps live.

Price. Both sit in the value tier of Korean toxins, below the better-known Nabota and Botulax price points. Typical retail band: roughly $22–55 per 100U vial, depending on channel and volume. FillersFairy currently lists Hutox 100U at $38.50 and Toxta 100U at $30.50.

Supply. Toxta carries a 36-month shelf life from manufacture — among the longest in the Korean market — reducing write-off risk for clinics that hold stock. Hutox has the longer distribution history and the deeper international channel, which is why you see it more often in wholesale lists.

Verifying authenticity — four checks that take two minutes:

  • 1Seal. Sterile-sealed with intact tamper evidence — reject anything pre-opened.
  • 2Batch. Batch number on box and vial matches and is traceable to the manufacturer.
  • 3Reconstitution behaviour. Hutox shows a visible powder that dissolves clear; Toxta’s near-empty film dissolves to the same clear solution. A product behaving differently than its form promises is a red flag.
  • 4Channel. Buy only through authorized cold-chain suppliers. Out-of-band pricing below the band above is the single biggest counterfeit signal in this market.

11Which Brand Fits Which Buyer

Your buying priority decides the pick — not the marketing sheet.

Choose Toxta

If your priority is unit cost and volume

The 36-month shelf life cuts inventory write-off, and balanced diffusion handles full-face and masseter work cleanly. The one adjustment is staff familiarity — the empty-looking vial takes exactly one unpacking to get used to.

Choose Hutox

If your priority is precision and the protein story

Glabella, periorbital, brow shaping — or you want the cleaner protein profile (150 kDa, no complexing proteins) and a brand name with broader international recognition, including its Liztox domestic track record.

The common answerMany practices stock both: Hutox for precise facial zones, Toxta for the volume areas. Same active molecule, different physical form and different spread behaviour — which is exactly why they are two products and not one.

12FAQ

Which works faster — Toxta or Hutox?
Both report onset around 3–7 days, with full effect at week two. Some Toxta distributors claim 2–3 days — treat that as marketing. No credible evidence puts either brand consistently ahead on onset.
Which lasts longer?
Both run 3–6 months in mainstream reports; 3–4 months is typical in domestic use. Some Toxta sellers quote 6–9 months — that is a distributor claim, not clinical data. Individual metabolism moves duration more than the brand does.
Both claim 99.8% purity. What is the real difference?
The purity figure is identical manufacturer marketing on both labels. The actual difference is protein: Hutox is a 150 kDa formulation without complexing proteins; Toxta is a reduced-protein complex. Both aim at the same lower-antibody-risk outcome by different routes.
Can I switch from Botox or Nabota to these? Are units interchangeable?
Switching is safe and common — the active molecule is the same type A toxin. Units are not interchangeable across brands: each product’s units are calibrated to its own formulation, and the practitioner recalibrates placement and dosing rather than converting from another brand’s chart.
Toxta has little public clinical data. Can it be trusted?
Toxta is MFDS-approved and has years of distributor-level use, but published trials are scarce — that is an honest gap, and we do not dress it up. Buy through authorized channels, validate the batch, and the practical track record is consistent with the rest of the Korean type A field.
How do I verify authenticity?
Four checks: intact sterile seal, traceable batch number, reconstitution behaviour matching the product form, and an authorized cold-chain channel. Any price well below the ~$22–55 band is the biggest counterfeit signal there is.
Is Hutox the same as Liztox?
Yes. Hutox is the English-market export name for the same Huons product that Korea’s domestic market sells as Liztox.

RReferences

  1. JETEMA Co., Ltd. Toxta product information — vacuum-dried botulinum toxin type A. 2026.
  2. Huons Global / Huons Biopharma. Hutox product information — freeze-dried botulinum toxin type A. 2026.
  3. Ministry of Food and Drug Safety (MFDS), Republic of Korea. Biologic product approval records.
  4. Carruthers J, Carruthers A. The evolution of botulinum toxin type A for cosmetic applications. J Am Acad Dermatol.
  5. Naumann M, Jankovic J. Safety of botulinum toxin type A: a systematic review and meta-analysis. Clin Pharmacol Ther.
  6. International Council for Commonality in Biologicals. Botulinum toxin products: considerations on standardisation and interchangeability. Biologicals.
  7. FillersFairy. Product pages: Toxta 100U; Hutox 100U. 2026.

Product specifics (unit sizes, pricing, current stock) should be confirmed on the live product pages before ordering. This article is a buyer-side comparison, not clinical guidance; all treatment decisions belong with a qualified practitioner.

Recommended Products